(Q47301503)

13 January 2018

title

Weight reduction effects of a black soy peptide supplement in overweight and obese subjects: double blind, randomized, controlled study (English)

1 reference

13 January 2018

0 references

Jung Hyun Kwak

1 reference

13 January 2018

Chang-Won Ahn

1 reference

13 January 2018

Soo-Hyun Park

1 reference

13 January 2018

Sung-Ug Jung

1 reference

13 January 2018

Byung-Jung Min

1 reference

13 January 2018

Oh Yoen Kim

1 reference

13 January 2018

Jong Ho Lee

1 reference

13 January 2018

publication date

28 June 2012

1 reference

13 January 2018

published in

Food & Function

1 reference

13 January 2018

volume

1 reference

13 January 2018

issue

1 reference

13 January 2018

page(s)

1019-1024

1 reference

13 January 2018

Contribution of visceral obesity to the deterioration of the metabolic risk profile in men with impaired glucose tolerance

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC2FO10244G

Health consequences of visceral obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO10244G

Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO10244G

Nutritional and health benefits of soy proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO10244G

Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO10244G

The effects of soy isoflavone on insulin sensitivity and adipocytokines in insulin resistant rats administered with high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO10244G

Effects of dietary equol on body weight gain, intra-abdominal fat accumulation, plasma lipids, and glucose tolerance in ovariectomized Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO10244G

Purification and identification of adipogenesis inhibitory peptide from black soybean protein hydrolysate

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO10244G

Weight loss and lipid changes with low-energy diets: comparator study of milk-based versus soy-based liquid meal replacement interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO10244G

Black Soy Peptide Supplementation Improves Glucose Control in Subjects with Prediabetes and Newly Diagnosed Type 2 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO10244G

Guidelines for healthy weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO10244G

A novel soy-based meal replacement formula for weight loss among obese individuals: a randomized controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO10244G

Novel black soy peptides with antiobesity effects: activation of leptin-like signaling and AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO10244G

Whey Protein but Not Soy Protein Supplementation Alters Body Weight and Composition in Free-Living Overweight and Obese Adults,

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO10244G

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO10244G

Drug Insight: the role of leptin in human physiology and pathophysiology--emerging clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO10244G

The role of leptin receptor signaling in feeding and neuroendocrine function

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO10244G

Obesity and the regulation of energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2FO10244G

21 January 2018

Identifiers

DOI

10.1039/C2FO10244G

1 reference

13 January 2018

1 reference

13 January 2018